И. Л. Давыдкин

632 total citations
97 papers, 332 citations indexed

About

И. Л. Давыдкин is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Epidemiology. According to data from OpenAlex, И. Л. Давыдкин has authored 97 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 20 papers in Hematology and 13 papers in Epidemiology. Recurrent topics in И. Л. Давыдкин's work include Hemophilia Treatment and Research (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (10 papers) and Neurological Disorders and Treatments (9 papers). И. Л. Давыдкин is often cited by papers focused on Hemophilia Treatment and Research (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (10 papers) and Neurological Disorders and Treatments (9 papers). И. Л. Давыдкин collaborates with scholars based in Russia, United States and China. И. Л. Давыдкин's co-authors include А. Н. Волобуев, N. Romanchuk, V. F. Pyatin, С. В. Булгакова, Valery P. Zakharov, Dmitry N. Artemyev, D.А. Kudlаy, Alexander Kulagin, D. V. Duplyakov and Ivan А. Bratchenko and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Medicine.

In The Last Decade

И. Л. Давыдкин

77 papers receiving 308 citations

Peers

И. Л. Давыдкин
Liang Mao China
Joel M. Goldman United States
Qian Guo China
Christian Arias‐Reyes Canada
K. Laiho Finland
Haoyu Wang China
Yue Chang China
Elizabeth S. Evans United States
Jenine K. Sanzari United States
Michael P. Grissom United States
Liang Mao China
И. Л. Давыдкин
Citations per year, relative to И. Л. Давыдкин И. Л. Давыдкин (= 1×) peers Liang Mao

Countries citing papers authored by И. Л. Давыдкин

Since Specialization
Citations

This map shows the geographic impact of И. Л. Давыдкин's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by И. Л. Давыдкин with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites И. Л. Давыдкин more than expected).

Fields of papers citing papers by И. Л. Давыдкин

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by И. Л. Давыдкин. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by И. Л. Давыдкин. The network helps show where И. Л. Давыдкин may publish in the future.

Co-authorship network of co-authors of И. Л. Давыдкин

This figure shows the co-authorship network connecting the top 25 collaborators of И. Л. Давыдкин. A scholar is included among the top collaborators of И. Л. Давыдкин based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with И. Л. Давыдкин. И. Л. Давыдкин is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukina, Elena, et al.. (2025). Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease. Terapevticheskii arkhiv. 97(2). 169–175.
2.
Kulagin, Alexander, et al.. (2024). Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria. Acta Haematologica. 148(4). 443–451. 1 indexed citations
3.
Рубаненко, О. А., et al.. (2024). Short Registry of Terminal Forms of Chronic Heart Failure in the Samara Region. Kardiologiia. 64(3). 46–54.
4.
5.
Давыдкин, И. Л., et al.. (2024). Gender cardiology: clinical and pathophysiological features of the course the main diseases in women. SHILAP Revista de lepidopterología. 114–121.
6.
Рубаненко, О. А., et al.. (2023). Comprehensive Analysis of Factors Associated with New Episode of Postoperative Atrial Fibrillation after Coronary Artery Bypass Graft Surgery. Life. 13(10). 2035–2035. 4 indexed citations
7.
Andreeva, T. A., В. В. Лебедев, Margarita Timofeeva, et al.. (2022). RESULTS OF OPEN, PROSPECTIVE, MULTICENTER, NON-COMPARATIVE STUDY OF NONACOG ALPHA PHARMACOKINETICS, EFFICACY AND SAFETY IN CHILDREN AGED 2–12 YEARS WITH SEVERE AND MODERATE HEMOPHILIA В. PEDIATRIA Journal named after G N SPERANSKY. 101(1). 193–201. 1 indexed citations
8.
Давыдкин, И. Л., et al.. (2022). Genetic polymorphisms associated with the development of arrhythmic type of cardiovascular events. SHILAP Revista de lepidopterología. 27(3S). 5069–5069.
9.
10.
Kulagin, Alexander, et al.. (2021). Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab. Annals of Hematology. 100(11). 2689–2698. 19 indexed citations
11.
Давыдкин, И. Л., et al.. (2020). Myocardial contractility dysfunction in patients with chronic lymphocytic leukemia receiving chemotherapy and their treatment with enalapril. SHILAP Revista de lepidopterología. 25(2). 90–97. 1 indexed citations
12.
13.
Давыдкин, И. Л., et al.. (2020). Endothelial dysfunction in patients with lymphoproliferative disorders and its changes in the course of polychemotherapy. SHILAP Revista de lepidopterología. 9(3). 3 indexed citations
14.
Давыдкин, И. Л., et al.. (2018). CLINICAL SIGNS OF CHEMOTHERAPY-INDUCED NEUROPATHY IN CANCER PATIENTS AND PHARMACOTHERAPY CORRECTION OPTIONS. The Russian Archives of Internal Medicine. 8(2). 137–144. 3 indexed citations
15.
Давыдкин, И. Л., et al.. (2018). Cardiovascular Toxicity of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia. Clinical oncohematology. 11(4). 378–387. 2 indexed citations
16.
Andreeva, T. A., et al.. (2018). Efficacy and safety of the drug Octofactor in prophylactic treatment in patients with severe haemophilia A. Russian Journal of Pediatric Hematology and Oncology. 5(3). 60–73. 2 indexed citations
17.
Andreeva, T. A., et al.. (2017). The efficacy and safety of the drug Octofactor in prophylactic treatment of adolescents with severe hemophilia A. Russian Journal of Pediatric Hematology and Oncology. 4(1). 61–70. 4 indexed citations
18.
Давыдкин, И. Л., et al.. (2017). RENAL-ASSOCIATED ESCAPE EFFECT OF ANTIHYPERTENSIVE THERAPY IN HYPERTENSIVE PATIENTS RECEIVING NONSTEROIDAL ANTI-INFLAMMA‑ TORY DRUGS (“PANDA” TRIAL). Arterial’naya Gipertenziya (Arterial Hypertension). 23(6). 517–528. 1 indexed citations
19.
Kaplanov, Kamil, et al.. (2012). Мутационный статус резистентных к иматинибу больных хроническим миелолейкозом. Oncohematology. 7(4). 16–23. 1 indexed citations
20.
Давыдкин, И. Л., et al.. (2009). Left ventricular remodeling in patients with chronic renal failure on outpatient hemodialysis. SHILAP Revista de lepidopterología. 21–24.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang Mao Breakdown of academic impact, for papers by Joel M. Goldman Breakdown of academic impact, for papers by Qian Guo Breakdown of academic impact, for papers by Christian Arias‐Reyes Breakdown of academic impact, for papers by K. Laiho Breakdown of academic impact, for papers by Haoyu Wang Breakdown of academic impact, for papers by Yue Chang Breakdown of academic impact, for papers by Elizabeth S. Evans Breakdown of academic impact, for papers by Jenine K. Sanzari Breakdown of academic impact, for papers by Michael P. Grissom
Rankless by CCL
2026